Xiu-lan Liu, Yi Liu, Lin Qiu, P. Luo, Jingjin Jin, Jian-ling Zheng, Dong Liu, Juan Li
{"title":"Pharmaceutical administration practice during prevention and treatment of COVID-19","authors":"Xiu-lan Liu, Yi Liu, Lin Qiu, P. Luo, Jingjin Jin, Jian-ling Zheng, Dong Liu, Juan Li","doi":"10.3760/CMA.J.CN112225-20200302-00440","DOIUrl":null,"url":null,"abstract":"January 25, 2020, our hospital was served as the designated hospital for critically ill patients with new coronary pneumonia in Wuhan. The timely and effective pharmaceutical emergency protection system was great significance for epidemic prevention. In order to ensure the drug demand of patients and improve the level of drug treatment, the key and difficult issues in the practice of pharmacy administration during new coronary pneumonia were combined with clinical practical work to develop an appropriate pharmaceutical emergency support system. Our department launched the emergency response mechanism, such as established list of COVID-19 key therapeutic drugs, urgently purchased therapeutic drugs, reformed the processes of emergency pharmacy, established a donated drug management system, establish the COVID-19 pharmaceutical care team, and opened a \"cloud pharmacy\" to meet the drug needs of non COVID-19 chronic diseases patients. We also strengthened the management of personnel protection. The pharmacy administration during new coronary pneumonia is a professional, comprehensive, complex and systematic emergency project that guarantees the safety of drug supply, medication and enables the treatment work to be carried out in an orderly manner. \n \nKey words: \nCOVID-19; Pharmacy administration; Clinical safe medication; COVID-19 hospital","PeriodicalId":56974,"journal":{"name":"中华医院管理杂志","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华医院管理杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.CN112225-20200302-00440","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
January 25, 2020, our hospital was served as the designated hospital for critically ill patients with new coronary pneumonia in Wuhan. The timely and effective pharmaceutical emergency protection system was great significance for epidemic prevention. In order to ensure the drug demand of patients and improve the level of drug treatment, the key and difficult issues in the practice of pharmacy administration during new coronary pneumonia were combined with clinical practical work to develop an appropriate pharmaceutical emergency support system. Our department launched the emergency response mechanism, such as established list of COVID-19 key therapeutic drugs, urgently purchased therapeutic drugs, reformed the processes of emergency pharmacy, established a donated drug management system, establish the COVID-19 pharmaceutical care team, and opened a "cloud pharmacy" to meet the drug needs of non COVID-19 chronic diseases patients. We also strengthened the management of personnel protection. The pharmacy administration during new coronary pneumonia is a professional, comprehensive, complex and systematic emergency project that guarantees the safety of drug supply, medication and enables the treatment work to be carried out in an orderly manner.
Key words:
COVID-19; Pharmacy administration; Clinical safe medication; COVID-19 hospital
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
